Health Tech

Mental disorders account for one of the largest and fastest growing categories of the burden of disease worldwide. Mental ill-health has devastating effect on individuals, families and communities, and weighs heavily on societies and economies - the economic burden of mental ill-health can rise to up to 4% of GDP, and those with mental illness have poorer educational and work outcomes than those in good mental health. Psylo is building a proprietary platform for developing psychedelic medicines to redefine how we treat mental illness. The Psylo team is uniquely positioned to transform mental health treatment with the application of psychedelics. Collectively, they bring years of experience researching cannabinoids and building deep biotech companies. And, like all great company-builders, the founding team has assembled a supporting tribe of industry-leading biotech investors and psychedelic experts.

Imagine a world where drugs are tested not on animals but on actual human cells before they reach clinical trials. Imagine that every patient could receive therapeutics that are proven to be effective on that particular patient, not just the general population. This could save years of trial and error and patient suffering. We’re thrilled to back SUN Biosciences, who are building the foundations for this future by standardising organoid culture to build a single source of biological truth for drug testing, development and application. Their unique technology solves some of the core issues that have been holding organoids back.

Avi Medical plans to operate modern and efficient medical centers to optimise and control the process of primary care, end-to-end. The medical centers are utilising state-of-the art digital infrastructure with an app for patients and a modern software stack for doctors. This brings process efficiency, a welcoming user experience before, during and after GP visits, 24/7 access to medical support and accurate diagnosis and treatments to the patients.

Beat 81’s sensors track heart rates during workouts and display them on a screen with additional in-app incentives to inspire competition for a personal best. Within the app, members can read a detailed report after each session, track their progress, book future classes and receive support from Beat81’s coaches.

In an easy to use app-based chat, patients with a subscription can pose an unlimited amount of questions. To ensure the quality of the provided medical help, Biloba engages freelance GPs and nurses on an hourly basis to quickly answer patients’ questions via a web-based platform.

Heidi is building the gateway for patients anywhere in the world to get the care they need rapidly, easily and cheaply while providing every doctor with the tools to provide modern care that is safe, productive and deeply satisfying.

There are two parts to the Flow Bio system, a sensor made up of electrodes and micro-fluidics channels (this part is disposable), and a shell that holds the battery, electronics, RAM etc. Data is then displayed on a connected app where FlowBio's own data will be displayed and can be connected to other 3rd party data. The first biomarkers will be potassium, sodium and sweat rate to provide the most comprehensive and real-time view into hydration status.

Exakt Health's mobile app leads users through "self-diagnosis" for standard sports injuries and offers customised professional physiotherapy plans for different conditions. Exakt will first focus on running-related injuries, prior to expanding to other rehabilitation segments. The app provides free and easy access to sports physiotherapists and doctors' expertise through modern technology. No commute. No waiting rooms.

Hello Inside provides the user with intelligent, personalised insights based on their food intake and glycemic response (the effect that food or meal has on blood sugar levels after consumption - something that differs for each of us). The Continuous Glucose Monitoring patch has a small, sub-cutaneous needle which detects the glucose levels in blood and transmits the readings via bluetooth to any connected device. Hello Inside will leverage this technology to build a personalised health platform for consumers.

With a strong foundation of fundamental research, Inventia has developed a proprietary platform encompassing drop-on-demand bio-printing technology, an expanding library of printable matrices and custom protocols for specific applications. The RASTRUM platform is now available to enable efficient and powerful bio-printing of 3D cell-based assays for biomedical research.

Zafrens exists to bring the life sciences to the AI era using cutting edge engineering tools. The costs and pace of data generation in biology/chemistry lag behind our ability to process data by many, many orders of magnitude. Zafrens aim to bridge this gap by developing ultra-high throughput, ultra-high resolution approaches to studying cells, both at the single-cell level and in the context of cell-cell interactions in various co-cultures. Considering the quickest way to understand complex systems is to perturb them, and thus the team have built a versatile platform that allows us to probe profound, complex questions by simply swapping the inputs to the system.

Tetratherix has developed a proprietary, fully synthetic biomaterial that is compatible with minimally invasive administration techniques and does not induce any foreign body reaction, a genuine biostealth platform technology. The company has active development programs in the areas of regenerative medicine and mRNA delivery. Our world-leading team has spent a decade, inventing and developing the biomaterial technology and has proven its safety and efficacy as the world’s first biostealth matrix.